By Mariam Sunny and Christy Santhosh (Reuters) - Biogen (NASDAQ:BIIB) beat first-quarter profit and revenue expectations on Thursday, as strong demand for its rare disease drugs helped offset declining sales of its multiple sclerosis medicines. The drugmaker has focused on deals, cost-cutting measures and newer drugs to address investor pressure for growth as demand falls for its once top-selling ...
By Allison Lampert and Utkarsh Shetti (Reuters) -Howmet Aerospace raised its 2025 profit forecast on Thursday, despite impacts from U.S. tariffs, sending shares up 7.8% as the maker of castings and fasteners expects to pass on higher costs and sees strong demand from increased jet production. The U.S. aerospace industry is seeking a tariff exemption to alleviate rising production costs and supply- ...
Investing.coom -- Citi Research has upgraded Derwent London (LON:DLN) to "buy" from "neutral," citing low valuation levels and resilient rental dynamics in the prime London office market, in a note dated Thursday. The price target was raised to £27.67 from £24.81, offering an expected total return of 48.2%.The analysts said Derwent’s shares are trading at levels typically seen during financi ...
By Savyata Mishra (Reuters) - McDonald’s (NYSE:MCD) posted a surprise drop in first-quarter global comparable sales on Thursday, as demand from cash-strapped diners in the U.S. and Europe faltered on uncertainty sparked by chaotic tariffs. The world’s largest fast-food chain is navigating the "toughest of market conditions", CEO Chris Kempczinski said as restaurant visits by lower- and middle- ...